SanofiMEX:SNY N 77 OCF Margin % is 28.35% as of Dec. 2025, which is 30% above its 10-year median of 21.76. GuruFocus rates MEX:SNY N with a GF Score™ of 77/100 and a GF Value™ of MXN1,061.60 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 959 Drug Manufacturers companies, Sanofi ranks better than 82.9% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sanofi's Cash Flow from Operations for the
six
months ended in Dec. 2025 was MXN151,699 Mil. Sanofi's Revenue for the
six
months ended in Dec. 2025 was MXN535,005 Mil. Therefore, Sanofi's OCF Margin % for the quarter that ended in Dec. 2025 was 28.35%.
The historical rank and industry rank for Sanofi's OCF Margin % or its related term are showing as below:
MEX:SNY N'
s OCF Margin % Range Over the Past 10 Years
Min: 15.55 Med: 21.76 Max: 26.86
Current: 22.91
During the past 13 years, the highest OCF Margin % of Sanofi was 26.86%. The lowest was 15.55%. And the median was 21.76%.
MEX:SNY N's OCF Margin % is ranked better than 82.9% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs MEX:SNY N: 22.91
Sanofi OCF Margin % Related Terms
Sanofi OCF Margin % Historical Data
* Premium members only.
The historical data trend for Sanofi's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:SNY N vs LLY, JNJ, ABBV: OCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Sanofi's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sanofi's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi (MEX:SNY N) has a OCF Margin % of 28.35% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sanofi and its competitors. This is 30% above median its historical median of 21.76. Over the past decade, Sanofi's OCF Margin % has ranged from 15.55 to 26.86. According to the industry distribution chart, Sanofi ranks #164 out of 959 companies in the Drug Manufacturers industry, placing it in the top 17.1%.
Is Sanofi's OCF Margin % too high?
Sanofi's current OCF Margin % of 28.35% is 30% above median its 10-year median of 21.76. Over the past 10 years, this metric has ranged from a low of 15.55 to a high of 26.86. The Drug Manufacturers industry median OCF Margin % is 9.95. Sanofi's value of 28.35% is 184.9% above this industry median. Based on the distribution chart, Sanofi ranks #164 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanofi's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi ranks #164 out of 959 companies for OCF Margin %. This places Sanofi in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Sanofi's value of 28.35% is 184.9% above this benchmark. Historically, Sanofi's own OCF Margin % has ranged from 15.55 to 26.86 over the past decade. While the company's 10-year median is 21.76 vs. the industry median of 9.95, Sanofi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi's current OCF Margin % of 28.35% is 184.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sanofi and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi's current OCF Margin % is 28.35%, which is 30% above median its own 10-year median of 21.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi stock overvalued right now?
Based on GuruFocus' analysis, Sanofi (MEX:SNY N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,061.60, compared to a current price of MXN730.00 — trading 31.2% below its estimated fair value. The current OCF Margin % is 28.35%, which is 30% above median its 10-year median of 21.76 and 184.9% above the Drug Manufacturers industry median of 9.95. Sanofi's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sanofi (MEX:SNY N), the current OCF Margin % is 28.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanofi (MEX:SNY N) Overvalued in 2026?
Based on GuruFocus' analysis, Sanofi stock appears to be undervalued.
The current stock price of MXN730.00 is trading 31.2% below its estimated GF Value™ of MXN1,061.60.
GuruFocus considers Sanofi to be Possible Value Trap.
Key valuation signals for MEX:SNY N:
OCF Margin %: 28.35% (30% above median its 10-year median of 21.76)
GF Value™: MXN1,061.60 vs. price of MXN730.00 (31.2% below fair value)
Industry Position: 184.9% above the Drug Manufacturers median (#164 of 959)
No single metric tells the full story. See the MEX:SNY N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
77GF Score
Get the complete analysis for MEX:SNY N
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:SNY N has been successfully added to your 
